: 23352394  [PubMed - indexed for MEDLINE]496. J Heart Lung Transplant. 2013 Feb;32(2):141-56. doi:10.1016/j.healun.2012.12.004.Fifth INTERMACS annual report: risk factor analysis from more than 6,000mechanical circulatory support patients.Kirklin JK(1), Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Timothy Baldwin J, Young JB.Author information: (1)University of Alabama at Birmingham, Birmingham, Alabama, USA.jkirklin@uab.eduThe 5th annual report of the Interagency Registry for Mechanically AssistedCirculatory Support (INTERMACS) summarizes and analyzes the first 6 years ofpatient and data collection. The current analysis includes more than 6000patients and updated risk factors for continuous flow pumps. Among continuousflow pumps, actuarial survival is 80% at 1 year and 70% at 2 years. Quality oflife indicators are generally favorable and adverse event burden will likelyinfluence patient selections of advanced heart failure therapies.Copyright Â© 2013 International Society for Heart and Lung Transplantation.Published by Elsevier Inc. All rights reserved.